Compare Hotel Mandarine Regency Tbk. (HOME) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hotel Mandarine Regency Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Hotel Mandarine Regency Tbk. trades at Rp50 (market cap 1.11T), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Hotel Mandarine Regency Tbk. is far larger — about 10.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| HOME | SCPI | |
|---|---|---|
Market Cap | 1.11T | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hotel Mandarine Regency Tbk.
PT Hotel Mandarine Regency Tbk (the Company) formerly known as PT Batam Jaya Hotel, was established through Notarial Deed No. 109 dated 28 October 1986 of Syawa Sutan Diatas, SH., a Notary in Pekanbaru. Based on the Notarial Deed No. 15 dated 4 November 1997 of Maria Hilaria Salim, SH., a Notary in Batam, the Company has changed its name from PT Hotal Batam Jaya to PT Hotal Mandarine Regency.
Read more on HOME →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
